-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$4.0025.79% Upside
Graphite Bio, Inc. Frequently Asked Questions
-
What analysts cover Graphite Bio, Inc.?
Graphite Bio, Inc. has been rated by research analysts at Morgan Stanley, RBC Capital, Leerink Partners, BMO Capital in the past 90 days.